Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for pulmonary hypertension secondary to COPD or sarcoidosis
2006-005361-19Phase 4Terminated
- Sponsor
- St George's Hospital
- Start
- Dec 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bosentan in pulmonary hypertension (PH) (2 arms), sponsored by St George's Hospital. Primary endpoint: Safety and tolerability. Started Dec 2006; status: terminated.
02
Drugs
bosentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2006-005361-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005361-19.